Dr. Joseph DeSanto and BioCorRx Recovery Program Participant Appear on the TV Show, The Doctors Feb 15, 2018
BioCorRx Announces Results of Pre-IND meeting with FDA for Sustained Release Naltrexone Implant, BICX102 Feb 12, 2018
BioCorRx Extends Service Agreement with Dr. Balbir S. Brar as VP of Drug Development Following Pre-IND Meeting with the U.S. FDA Feb 8, 2018
BioCorRx Completes Pre-IND Meeting with FDA; Reports Company to Move Forward with BICX102 Jan 26, 2018
CORRECTION: CEO, Brady Granier, From BioCorRx® Inc. Discusses Upcoming FDA Meeting on “Stock Day” Podcast; Aims to Fight Opioid Crisis Jan 22, 2018
CEO, Brady Grainer, From BioCorRx®Inc. Paves Pathway Towards Possible FDA Approval on “Stock Day” Podcast; Aims to Fight Opioid Crisis Jan 22, 2018
